NPI registry status
Active
2026 NPPES data Interventional Pain Medicine Physician NPI 1245228766 M.D., M.B.A
Verify on CMS → Ruben Kalra, M.D., M.B.A
Interventional Pain Medicine Physician in Pleasant Hill, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,528 in Interventional Pain Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
442
Medicare Part D claims · 134 beneficiaries · Interventional Pain Medicine Physician avg: 2K
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
88.4/100
▲ 5 pts above national avg 83.1 · Above neutral
Industry payments
$339.71
8 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Ruben Kalra, M.D., M.B.A reported a CMS MIPS final score of 88.4/100 - above the 83.1 national average - and filed 442 Medicare Part D claims in 2023.
- 88.4/100
- MIPS score · +5 vs avg
- 442
- Part D claims, 2023
- 93%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Ruben Kalra, M.D., M.B.A's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
88 Top 44% higher than 56% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Ruben Kalra, M.D., M.B.A sits
This provider among interventional pain medicine physician peers
Across the 546 interventional pain medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Ruben Kalra, M.D., M.B.A writes more Part D claims than 19% of them and scores higher on MIPS quality than 72% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one interventional pain medicine physician peer from a representative sample of 60; the gold marker is Ruben Kalra, M.D., M.B.A. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Ruben Kalra, M.D., M.B.A practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ruben Kalra, M.D., M.B.A?
High performer (top quartile)Primary specialty
Interventional Pain Medicine Physician
Medicare Part D claims
442 80% vs specialty avg
MIPS final score
88.4/100 5.3 pts vs avg
Specialty distribution in California
How Interventional Pain Medicine Physician compares to other specialties among California providers
Medicare quality performance, MIPS
Ruben Kalra, M.D., M.B.A's 2023 MIPS final score plotted against the Interventional Pain Medicine Physician national average
- MIPS Final Score
- 88.4/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Interventional Pain Medicine Physician) - 88.4/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Ruben Kalra, M.D., M.B.A appears in the CMS NPPES registry as a Interventional Pain Medicine Physician provider holding M.D., M.B.A credentials at 2250 MORELLO AVE, Pleasant Hill, CA, 94523, with a listed phone of (925) 287-1256. NPI 1245228766 was issued on 10/10/2005.
Medicare Part D records for calendar year 2023 show 442 prescription claims written by this provider, covering 134 Medicare beneficiaries and totaling roughly $25K in drug spend, split 7% brand-name and 93% generic by claim count, with an opioid prescribing rate of 44.8%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 88.4/100 for the 2023 performance year (Quality 78.9), compared with the national average of 83.1.
Interventional Pain Medicine Physician is a narrow specialty nationwide, with 1,528 enrolled providers across 53 states and an average of 2,197 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1245228766 |
|---|---|
| Specialty | Interventional Pain Medicine Physician |
| Credentials | M.D., M.B.A |
| Gender | Male |
| NPI Issued | 10/10/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
88.3716
Final Score
Avg: 83.1
78.8574
Quality
100
Promoting Interoperability
Reporting: Individual
Hospital and facility affiliations
Facilities where Ruben Kalra, M.D., M.B.A bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Bass Medical Group
Alamo, CA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ruben Kalra, M.D., M.B.A. Source: openpaymentsdata.cms.gov.
Total received
$340
Largest payer
PAINTEQ LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Ruben Kalra, M.D., M.B.A. To verify Ruben Kalra, M.D., M.B.A's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Ruben Kalra, M.D., M.B.A - brand share 7.0%
Interventional Pain Medicine Physician average
7% brand-name claims vs 93% generic, on 442 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
442
Total Claims
$25K
Total Drug Cost
134
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 512
- Total Day Supply
- 12,770
- Brand vs Generic
- 7% brand / 93% generic
- Brand Drug Cost
- $9K
- Generic Drug Cost
- $17K
- Opioid Claims
- 198 (44.8% rate)
Patient Demographics
- Average Patient Age
- 73.4 years
- Avg HCC Risk Score
- 1.36
- Gender Split
- 60% female / 40% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Ruben Kalra, M.D., M.B.A prescribes most
Top Medicare Part D drugs by claim count, 2023
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
47 claims
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
41 claims
- Baclofen
Baclofen
33 claims
- Oxycodone Hcl
Oxycodone Hcl
29 claims
- Gabapentin
Gabapentin
26 claims
- Cyclobenzaprine Hcl
Cyclobenzaprine Hcl
24 claims
- Hydromorphone Hcl
Hydromorphone Hcl
20 claims
- Celecoxib
Celecoxib
19 claims
| Drug | Claims |
|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 47 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 41 |
| Baclofen | 33 |
| Oxycodone Hcl | 29 |
| Gabapentin | 26 |
| Cyclobenzaprine Hcl | 24 |
| Hydromorphone Hcl | 20 |
| Celecoxib | 19 |
| Lidocaine | 19 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 17 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Interventional Pain Medicine Physician in CA →
All providers in California →
Compare specialties →
Interventional Pain Medicine Physician Overview
How Ruben Kalra, M.D., M.B.A fits within the Interventional Pain Medicine Physician landscape nationally.
1,528
Interventional Pain Medicine Physician Providers in US
53
States with Interventional Pain Medicine Physician
2,197
Avg Claims per Provider
Ruben Kalra, M.D., M.B.A's 442 claims are below the specialty average of 2,197.
Nearby Interventional Pain Medicine Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Kalra.
Dr. Hussein Abdulhadi
M.D.
La Mesa, CA
Dr. Nader Achackzad
M.D.
Santa Clara, CA
Dr. Patrick Akin
DO
Turlock, CA
Dr. Kais Alsharif
MD
Long Beach, CA
Dr. Pari Azari
M.D.
Clearlake, CA
Compare Interventional Pain Medicine Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Interventional Pain Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore California
Frequently Asked Questions
What is Ruben Kalra, M.D., M.B.A's specialty? ▼
Ruben Kalra, M.D., M.B.A specializes in Interventional Pain Medicine Physician and practices in Pleasant Hill, California. Credentials: M.D., M.B.A.
How much does Ruben Kalra, M.D., M.B.A prescribe under Medicare Part D? ▼
In 2023, Ruben Kalra, M.D., M.B.A wrote 442 Medicare Part D claims totaling $25K in drug costs for 134 beneficiaries.
What is Ruben Kalra, M.D., M.B.A's Medicare quality score? ▼
Ruben Kalra, M.D., M.B.A has a CMS MIPS Final Score of 88.4/100 (Quality: 78.9). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Ruben Kalra, M.D., M.B.A located? ▼
Ruben Kalra, M.D., M.B.A is located at 2250 MORELLO AVE, Pleasant Hill, CA, 94523. Phone: (925) 287-1256.
What is Ruben Kalra, M.D., M.B.A's NPI number? ▼
Ruben Kalra, M.D., M.B.A's National Provider Identifier (NPI) is 1245228766, issued on 10/10/2005.
Does Ruben Kalra, M.D., M.B.A prescribe more brand-name or generic drugs? ▼
Ruben Kalra, M.D., M.B.A's prescribing is 7% brand-name and 93% generic drugs by claim count, with $9K in brand drug costs.
Does Ruben Kalra, M.D., M.B.A prescribe opioids? ▼
Yes, Ruben Kalra, M.D., M.B.A had 198 opioid claims in 2023 with an opioid prescribing rate of 44.8%.
How many Interventional Pain Medicine Physician providers are there in the US? ▼
There are 1,528 Interventional Pain Medicine Physician providers across 53 states in the US. The average Interventional Pain Medicine Physician provider writes 2,197 Medicare Part D claims per year.
What drugs does Ruben Kalra, M.D., M.B.A prescribe most often? ▼
Based on 2023 Medicare Part D data, Ruben Kalra, M.D., M.B.A's most frequently prescribed drugs include Hydrocodone-Acetaminophen, Oxycodone-Acetaminophen, Baclofen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ruben Kalra, M.D., M.B.A accept Medicare? ▼
Ruben Kalra, M.D., M.B.A appears in CMS Medicare data with 442 Part D claims and 134 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ruben Kalra, M.D., M.B.A's credentials? ▼
Ruben Kalra, M.D., M.B.A's NPI is 1245228766 with credentials M.D., M.B.A. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.